4D pharma PLC Sponsored ADR LBPS

Market cap
$37.2M
P/E
0.0×
Growth Flags show if company had growth for consecutive years
Dec '21 Jun '21 Feb '21 Dec '20 Older periods
P/E ratio
0.00 0.00 — 0.00

+8 more quarters

P/S ratio
697.71 1,323.42 — 0.00
P/FCF ratio
0.00 0.00 — 0.00
P/Operating CF
(51.89) (106.61) — (6.29)
P/B ratio
31.35 30.86 — 4.36
Price to Tangible BV
76.45 47.29 — 8.87
EV/Sales
692.37 1,302.08 — 0.00
EV/EBITDA
0.00 0.00 — 0.00
EV/Operating CF
(10.96) (23.99) — (3.57)
EV/FCF
(10.81) (23.58) — (3.57)
Quick Ratio
4.71 4.18 1.97 1.97
Current Ratio
5.21 4.22 2.45 2.45
Net Debt/EBITDA
0.42 1.60 0.31 0.31
Debt/Assets
23.13% 1.96% 2.22% 2.22%
Debt/Equity
0.43 0.02 0.03 0.03
Asset Turnover
0.04 0.03 0.00 0.00
Operating CF/Net income
(9.41) 0.21 0.90 0.90
Capex/Depreciation
0.00 (0.22) (0.13) (0.15)
Interest Coverage
— — 0.00 0.00
Research and Development Expense of Revenue
3,298.97% 4,100.87% — 3,715.44%
Selling, General and Administrative Expense of Revenue
1,314.78% 0.00% — 0.00%
Intangible Assets out of Total Assets
0.32 0.29 0.40 0.40
Share Based Compensation of Revenue
0.00% 0.00% 0.00% 0.00%
Graham Net Nets
0.01 0.02 — 0.06
Graham Number
0.00 0.00 — 0.00
Earnings Yield
(12.34%) (7.29%) — (3.97%)
Free Cash Flow Yield
(9.18%) (4.17%) — (26.23%)
Revenue per Share
0.00 0.00 — 0.00
Operating CF per Share
(0.10) (0.10) 0.00 (1.90)
Capex per Share
0.00 0.00 0.00 (0.02)
Free Cash Flow per Share
(0.10) (0.10) 0.00 (1.91)
Cash per Share
0.12 0.18 0.00 0.84
Shareholders Equity per Share
0.17 0.35 0.00 2.73
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
0.17 0.35 0.00 2.73
Free Cash Flow
(18.94) (16.21) (27.16) (27.29)
Working Capital
27.84 31.69 12.34 12.34
Capital Expenditures
(0.12) (0.16) (0.21) (0.23)
Net Current Asset Value
7.77 30.36 10.72 10.72
EV/EBIT
0.00 0.00 — 0.00
Capex to Sales
0.00 0.00 0.00 0.00
Net Profit Margin
512.03% 0.00% 0.00% 0.00%
Price to Operating Income
0.00 0.00 — 0.00
Other line items
Average Receivables
11.45 9.57 5.92 8.21
Average Payables
3.45 5.03 6.23 2.43
Average Inventory
0.31 0.40 — 0.38
Average Assets
36.33 40.57 49.21 45.83
Average Common Equity
18.17 30.22 38.90 21.99

Fold the line items

Columns are period end dates